The authors studied retrospectively 16 cases of malignant epithelial nasopharyngeal tumors which were treated at the Head and Neck Service of the Heliópolis Hospital, São Paulo, Brasil, from December 1977 to December 1983. The treatment was intra-arterial chemotherapy (IAC) followed by radiotherapy. The chemotherapeutic schedules were: a) methotrexate and vincristine, b) methotrexate, bleomycin and vincristine (2 different schedules) and c) methotrexate, bleomycin, vincristine and cisplatinum. Objective responses to IAC were observed in 18.6 % of the cases. Only 3 patients are alive at 26, 37 and 53 months; 2 of them had exhibited response to IAC. The authors analyze the results and suggest randomized trials in order to determine the exact effects of this method of treatment.
Get full access to this article
View all access options for this article.
References
1.
BarbosaJ.F.: Câncer da Faringe.Editora Manole. São Paulo, 1979.
BertinoJ.R., MosherM.B., De ContiR.C.: Chemotherapy of cancer of the head and neck.Cancer, 31: 1141–1149, 1973.
4.
BlumR.H., CarterS.K., AgreK.: A clinical review of bleomycin - A new antineoplastic agent.Cancer, 31: 903–914, 1973.
5.
CapelanoR.: Quimioterapia Antineoplásica por Infusão Arterial, Indicaçōes para o Tratamento des Tumores de Cabeça e Pescoço.Bol. Oncol., 46: 358–359, 1963.
6.
CinbergJ.Z., ChangT.H., HebbardP., BasesR., VoglS.E.: An application of immunocytology to the analysis of the cell kinetics of upper respiratory and digestive tract squamous carcinoma.Cancer, 51: 1843–1846, 1983.
7.
CreaganE.T., O'FassonJ.R., WoodsJ.E., IngleJ.N., SchuttA.J., NicholsW.C.: Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer.Cancer, 51: 2020–2023, 1983.
8.
DeckerD.A., DrelichmanA., Al-SarrafM., CrissmanJ., ReedM.I.: Chemotherapy for nasopharyngeal carcinoma - A ten year experience.Cancer, 52: 602–605, 1983.
9.
De ContiR.C., SchoenfeldD.: A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and methotrexate combination in head and neck cancer.Cancer, 48: 1061–1072, 1981.
10.
DeutschM., MercadoR.Jr., ParsonJ.A.: Cancer of the nasopharynx in children.Cancer, 41: 1128–1135, 1978.
11.
DonegasW.L., HarrisH.S.: Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.Am. J. Surg., 123: 549–559, 1972.
12.
DrelichmanA., CummingsG., Al-SarrafM.: A randomized trial of the combination of cis-platinum, Oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.Cancer, 52: 399–403, 1983.
13.
FishU.: The infratemporal fossa approach for nasopharyngeal tumors.Laryngoscope, 93: 36–44, 1983.
14.
FreckmanH.A.: Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.Am. J. Surg., 124: 501–509, 1972.
15.
GoldsmithM.A., CarterS.K.: The integration of chemotherapy into a combined modality approach to cancer therapy.Cancer Treat. Rev., 2: 137–158, 1975.
16.
HongW.K., SchaeferS., IsraelS., CummingsG., LuedkeD., BromerR., FofonaffS., D'AcustJ., ShapsayS., WelchJ., LevinE., VincentM., VaughanC., StrongS.: A prospective randomized trial of methotrexate versus cisplatin in treatment of recurrent squamous cell carcinoma of the head and neck.Cancer, 52: 206–210, 1983.
17.
KligermanM.N., HellmanS., Von EssenC.F., BertinoJ.R.: Sequential chemotherapy and radiotherapy.Radiology, 86: 247–250, 1966.
18.
KloopC.T., AlfordT.C., BatemanJ., BerryG.N., WinshopT.: Fractioned intra-arterial cancer chemotherapy with methyl bis amine hydrochloride. A preliminary report.Ann. Surg., 132: 811–832, 1950.
19.
KramerS.: Radiation therapy and chemotherapy combination.JAMA, 217: 946–947, 1971.
20.
KuklaL.J., MantravadiV.P., AppebaumE.L., McGuireW.P.: Preirradiation chemotherapy for advanced head and neck carcinoma.Arch. Otolaryngol., 110: 78–81, 1984.
21.
MoenchH.C., PhillipsT.L.: Carcinoma of the nasopharynx - Review of 146 patients with emphasis on radiation dose and time factors.Am. J. Surg., 124: 515–518, 1972.
22.
NahumA.M.: Limitations imposed by head and neck vasculature on regional chemotherapy.Surg. Gynecol. Obstet., 116: 539–546, 1963.
23.
NahumA.M., RochlinD.: Regional arterial chemotherapy of cancer of the head and neck.Surg. Gynecol. Obstet., 115: 478–483, 1962.
24.
NerviC., ArcangeliG., CasaleC., CorteseM., GuadagniA., LePeraV.: A reappraisal of intraarterial chemotherapy.Cancer, 26: 577–582, 1970.
25.
PerezC.A., AckermanL.V., MillW.B., OguraJ.H., PowersW.F.: Cancer of the nasopharynx - Factors influencing prognosis.Cancer, 29: 1–17, 1969.
26.
PriceL.A., HillB.T., CalvertA.H., ShawH.J., HughesK.B.: Kinetically-based multiple drug treatment for advanced head and neck cancer.Br. Med. J., 3: 10–11, 1975.
27.
RapoportA., Andrade SobrinhoJ., MottaN.W.: A Quimioterapia Intra-Arterial no Tratamento das Neoplasias Malignas da Cabeça e Pescoço.Rev. Bras. Cir. Cab. Pesc., 2: 57–80, 1975.
28.
RapoportA., Andrade SobrinhoJ., SersonD., NunesJ.E.O.: The value of I191 labeled albumin macroaggregate in the localization of intra-arterial chemotherapy for the treatment of advanced cancer of the head and neck.Tumori, 60: 355–359, 1974.
29.
RapoportA., CarvalhoM.B., Andrade SobrinhoJ., MagrinJ., SersonD., NunesJ.E.O.: A Infusão Arterial no Tratamento do Câncer Avançado de Cabeça e Pescoço - Estudo de 250 casos.Acta Oncol. Bras., 1: 6–13, 1977.
30.
SchaebelF.M.Jr.: The use of tumor growth kinetics in planning «curative » chemotherapy of advanced solid tumors.Cancer Res., 29: 2384–2389, 1969.
31.
SchaeferS.D., MiddletonR., ReischJ., FrankelE.P.: Cis-platinum induction chemotherapy in the multi-modality initial treatment of advanced stage IV carcinoma of the head and neck.Cancer, 51: 2168–2174, 1983.
32.
SchmauzR., TempletonA.C.: Nasopharyngeal carcinoma in Uganda.Cancer, 29: 610–621, 1972.
33.
SilverA.J., MawadM.E., HilalS.K., SaneP., GantiS.R.: Computed tomography of the nasopharynx and related spaces.Part I. Radiology, 147: 725–731, 1983.
34.
SilverA.J., MawadM.E., HilalS.K., SaneP., GantiS.R.: Computed tomography of the nasopharynx and related spaces.Part II. Radiology, 147: 733–738, 1983.
35.
SullivanR.D.: Continuous arterial infusion cancer chemotherapy.Surg. Clin. North Am., 42: 365–388, 1962.
UICC - TNM Classification of Malignant Tumours.Third Edition.UICC, Geneva, 1978.
38.
VitaH.C., MendiondoO.A., ShawD.L., JeldenG., ReneJ.B., FriasZ., SomeronA.: Nasopharyngeal carcinoma in the second decade of life.Radiology, 148: 253–256, 1983.
39.
WatkinsE., SullivanR.D.: Cancer chemotherapy by prolonged arterial infusion.Surg. Gynecol. Obstet., 118: 3–19, 1964.
40.
WoodsJ.E.: Current status of chemotherapy in the treatment of head and neck cancer.Arch. Surg., 111: 1055–1056, 1976.
41.
YehS.: A histological classification of carcinoma of the nasopharynx with a critical review as to the existence of lymphoepitheliomas.Cancer, 15: 895–920, 1962.
